Following a recent surge in vision-loss claims, the FDA is intensifying its focus on NAION
Accordingly, a cohort study found no association between the exposure to GLP-1R agonists and diabetic retinopathy, and in fact GLP-1R agonists were found to even decrease the risk of diabetic retinopathy by 33% when compared to new-users of insulin (Douros et al., 2018)
And I'm a big fan of that because as a clinician you need some guide, some efficient and effective way to treat the patient in front of you
Thus, TMAO is part of a complicated biochemical pathway and focusing on levels of the molecule in isolation as a red flag for cardiovascular disease may present an incomplete picture, they said
Not just practical concern, but something more personal
Consider confirming that you have: your GLP-1 injection pen enough medication for the entire trip spare needles if required alcohol swabs a small sharps container or travel needle case an insulated pouch or cooling pack if travelling in warm climates a copy of your prescription or medication label Keeping these items together in a small travel pouch can make injections much easier to manage while away from home
